OverlTherapeutics is a cross-border biotechnology company with a mission of accelerating the global development of first best-in- cell therapies. Headquartered in South San Francisco, OverlTx has established fully integrated, cross-border cell therapy research, development, GMP manufacturing capabilities. OverlTx is developing both autologous allogeneic cell therapies to address significant patient unmet needs in hematological mancies autoimmune diseases.
内容由
提供
恭喜您，提交成功！
您的编辑正在审核中，1个工作日内，会以邮件通知您结果
提交失败。
